KIT COMBO FLU A B COVID19 TEST RAPID IMMUNOASSAY INFLUENZA

Status Covid-19/Flu A&B. A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens. COVID-19 - Anterior nasal swab specimen. 1 test + 1 specimen = 3 Results. - Sensitivity 93.8 %, Specificity 100%. - Nasopharyngeal - Sensitivity 93.1 %, Specificity 100%. Flu A - Sensitivity 91.4%, Specificity 95.7%. Flu B - Sensitivity 87.6%, Specificity 95.9%. FDA Emergency Use Authorization (EUA). Visually read in 15 minutes. Flocked specimen swabs for superior specimen collection and patient comfort. Status COVID-19/Flu A& B is an antigen test for use with nasal and nasopharyngeal swab specimens. Status COVID-19/Flu A & B test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting. During the duration of the emergency this test can be performed in a patient care setting that is operation under a CLIAWaiver, Certificate of Compliance, or Certificate of Accreditation. UOM: 25TESTS/BX, 20BX/CS, 500TESTS.